1. Home
  2. Industry News

Bayers registered 6% leap in Revenue from Operations

Bayer CropScience Limited, a global enterprise with core competencies in the Life Science fields of health care and agriculture announced its unaudited results for the quarter and half-year ended September 30, 2017. For the quarter ended September 30, 2017, the Company registered Revenue from Operations of Rs.12,320 million for FY 2017-18, marking an increase of 6 percent from Rs.11,600 million for the corresponding quarter in FY 2016-17. The Company reported Profit for the period of Rs.1,906 million. Its products and services are designed to benefit people and improve their quality of life.

KJ Staff



Bayer CropScience Limited, a global enterprise with core competencies in the Life Science fields of health care and agriculture announced its unaudited results for the quarter and half-year ended September 30, 2017. For the quarter ended September 30, 2017, the Company registered Revenue from Operations of Rs.12,320 million for FY 2017-18, marking an increase of 6 percent from Rs.11,600 million for the corresponding quarter in FY 2016-17. The Company reported Profit for the period of Rs.1,906 million. Its products and services are designed to benefit people and improve their quality of life.

Commenting on the second quarter results and future outlook, Richard van der Merwe, Vice Chairman & Managing Director, Bayer CropScience Limited, said, “We achieved a 6 percent growth in Q2, FY 2017-18 compared to Q2, FY 2016-17. Sales figures for the corresponding quarter of last year included excise duty, which is now included in GST. Liquidation continued to be impacted because of erratic monsoons and uneven rainfall distribution. Looking ahead, we expect the difficult market conditions to persist. Therefore our outlook for Q3 remains modest.”

For the half-year ended September 30, 2017, the Company registered Revenue from Operations of Rs.19,691 million, compared to Rs.20,155 million for the corresponding quarter in H1 FY 2016-17. The half-yearly performance was affected due to a poor first quarter and the impact of GST introduction. The Company reported Profit for the period of Rs.3,023 million in H1 FY 2017-18.

Elaborating on the highlights for H1 FY 2017-18, Mr. van der Merwe said, “Bayer CropScience Limited continued to introduce innovation to the Indian market in the form of new product launches. In Crop Protection, we launched two new insecticides: Sivanto prime for okra and Movento for chillies. We also launched a new fungicide, Emesto Prime for potatoes. In Seeds, we launched three new rice hybrids: Arize AZ 8433 DT, Arize AZ 6453 and Arize AZ 6508. Arize 8433 DT in particular, is our hybrid rice seed with inbuilt protection against one of the worst pests in Indian rice fields: the brown plant hopper (BPH). In Environmental Science, we launched Maxforce Quantum, an insecticide for professional pest management of ants.”

 

Take this quiz to know more about radish Take a quiz

Related Articles

Share your comments
FactCheck in Agriculture Project

Subscribe to our Newsletter. You choose the topics of your interest and we'll send you handpicked news and latest updates based on your choice.

Subscribe Newsletters